Skip to main content
Log in

The Combination Formulation of Clindamycin 1% plus Benzoyl Peroxide 5% versus 3 Different Formulations of Topical Clindamycin Alone in the Reduction of Propionibacterium acnes

An In Vivo Comparative Study

  • Original Research Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Background

Isolates of Propionibacterium acnes resistant to one or more anti-acne antibiotics (most commonly erythromycin) are being increasingly reported, and the emergence of resistant strains can be associated with therapeutic failure of topical treatment.

Objective

Comparison of the in vivo effectiveness of the combination of clindamycin 1% plus benzoyl peroxide 5% in a gel formulation to that of each of 3 clindamycin 1% preparations (gel, lotion, and solution) with respect to reduction in counts of P. acnes cultured from the foreheads of healthy volunteers.

Methods

The effects of treatment with the 4 study drugs were compared in an open-label study. Cultures were collected before, after 1 week and after 2 weeks of treatment.

Results

Treatment with the combination formulation resulted in a 99.8% (>2 logs) reduction in total propionibacterial numbers after 1 week of therapy compared with 30 to 62% (<1 log) decreases for the different formulations of topical clindamycin alone. By the end of week 2, the combination had decreased P. acnes counts by more than 99.9% (>3 logs) relative to reductions of from 88 to 95% (< or > 1 log) for the single agent formulations.

Conclusions

Under the conditions of the present study, the combination of clindamycin 1% plus benzoyl peroxide 5% gel produced more rapid and highly significant reductions in P. acnes compared with formulations containing clindamycin alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Fig. 1

Similar content being viewed by others

References

  1. Leyden J.J., McGinley K.J., Vowels B. Propionibacterium acnes colonization in acne and nonacne. Dermatology 1998; 196: 55–58

    Article  PubMed  CAS  Google Scholar 

  2. Weiss J. Current options for the topical treatment of acne vulgaris. Pediatr Dermatol 1997; 14: 480–488

    Article  PubMed  CAS  Google Scholar 

  3. Eady E.A. Bacterial resistance in acne. Dermatology 1998; 196: 59–66

    Article  PubMed  CAS  Google Scholar 

  4. Espersen F. Resistance to antibiotics used in dermatological practice. Br J Dermatol 1998; 139: 4–8

    Article  PubMed  CAS  Google Scholar 

  5. Leyden J.J., McGinley K.J., Cavalieri S., et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983; 8: 41–45

    Article  PubMed  CAS  Google Scholar 

  6. Nishijima S., Akamatsu H., Akamatsu M., et al. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne. J Dermatol 1994; 21: 166–171

    PubMed  CAS  Google Scholar 

  7. Eady E.A., Farmery M.R., Ross J.I., et al. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol 1994; 131: 331–336

    Article  PubMed  CAS  Google Scholar 

  8. Eady E.A., Bojar R.A., Jones C.E., et al. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 1996; 134: 107–113

    Article  PubMed  CAS  Google Scholar 

  9. Vermeulen B., Remon J.P., Nelis H. The formulation and stability of erythromycinbenzoyl peroxide in a topical gel. Int J Pharm 1999; 178: 137–141

    Article  PubMed  CAS  Google Scholar 

  10. Gruber M.P., Klein R.W. Determination of benzoyl peroxide stability in pharmaceuticals. J Pharm Sci 1967; 56: 1505–1508

    Article  PubMed  CAS  Google Scholar 

  11. Guin J., Reynolds R., Gielerak P. Penetration of topical clindamycin into comedones. J Amer Acad Dermatol 1980; 3: 153–156

    Article  CAS  Google Scholar 

  12. Williamson P., Kligman A. A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol 1965; 45: 498–503

    Article  PubMed  CAS  Google Scholar 

  13. Lookingbill D.P., Chalker D.K., Lindholm J.S., et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 1997; 37: 590–595

    Article  PubMed  CAS  Google Scholar 

  14. Tucker S.B., Tausend R., Cochran R., et al. Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris. Br J Dermatol 1984; 110: 487–492

    Article  PubMed  CAS  Google Scholar 

  15. Dhawan V., Thadepalli H. Clindamycin: a review of fifteen years of experience. Rev Infect Dis 1982; 4: 1133–1153

    Article  PubMed  CAS  Google Scholar 

  16. Nacht S., Yeung D., Beasley J.J., et al. Benzoyl peroxide: percutaneous penetration and metabolic disposition. J Am Acad Dermatol 1981; 4: 31–37

    Article  PubMed  CAS  Google Scholar 

  17. Leyden J., Hickman J., Jarratt M., et al. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared to benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. J Cut Med Surg 2001; 5: 37–42

    CAS  Google Scholar 

  18. Leyden J., Berger R., Dunlap F., et al. Comparison of a combination topical gel formulation (benzoyl peroxide/clindamycin) with benzoyl peroxide, clindamycin and vehicle gel treatments for acne vulgaris. Am J Clin Derm 2000; 2: 39

    Google Scholar 

  19. Tschen E., Katz H., Jones T., et al. A combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris. Cutis 2001; 67: 165–169

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This investigation was supported by Dermik Laboratories.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sharon F. Levy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leyden, J., Kaidbey, K. & Levy, S.F. The Combination Formulation of Clindamycin 1% plus Benzoyl Peroxide 5% versus 3 Different Formulations of Topical Clindamycin Alone in the Reduction of Propionibacterium acnes . Am J Clin Dermatol 2, 263–266 (2001). https://doi.org/10.2165/00128071-200102040-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200102040-00007

Keywords

Navigation